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Abstract	
Emulsion-templated	 (polyHIPE)	 scaffolds	 for	 bone	 tissue	 engineering	 were	 produced	 by	
photopolymerisation	 of	 a	 mixture	 of	 trimethylolpropane	 tris(3-mercaptopropionate)	 and	
dipentaerythritol	penta-/hexa-acrylate	in	the	presence	of	hydroxyapatite	(HA)	or	strontium-
modified	 hydroxyapatite	 (SrHA)	 nanoparticles.	 Porous	 and	 permeable	 polyHIPE	 materials	
were	 produced	 regardless	 of	 the	 type	 or	 incorporation	 level	 of	 the	 bioceramic,	 although	
higher	loadings	resulted	in	a	larger	average	pore	diameter.	Inclusion	of	HA	and	SrHA	into	the	
scaffolds	was	 confirmed	 by	 EDX-SEM,	 FTIR	 and	 XPS	 and	 quantified	 by	 thermogravimetry.	
Addition	of	HA	to	polyHIPE	scaffolds	significantly	enhanced	compressive	strength	(148-216	
kPa)	without	affecting	compressive	modulus	(2.34-2.58	MPa).	The	resulting	materials	were	
evaluated	in	vitro	as	scaffolds	for	the	3D	culture	of	MG63	osteoblastic	cells	vs	a	commercial	
3D	 cell	 culture	 scaffold	 (Alvetex®).	 Cells	 were	 able	 to	 migrate	 throughout	 all	 scaffolds,	
achieving	a	high	density	by	the	end	of	the	culture	period	(21	days).	The	presence	of	HA	and	
in	 particular	 SrHA	 gave	 greatly	 enhanced	 cell	 proliferation,	 as	 determined	 by	 staining	 of	
histological	sections	and	total	protein	assay	(Bradford).	Furthermore,	Von	Kossa	and	Alizarin	
Red	staining	demonstrated	significant	mineralisation	from	inclusion	of	bioceramics,	even	at	
the	earliest	time	point	(day	7).	Production	of	alkaline	phosphatase	(ALP),	an	early	osteogenic	
marker,	was	used	 to	 investigate	 the	 influence	of	HA	and	SrHA	on	cell	 function.	ALP	 levels	
were	significantly	reduced	on	HA-	and	SrHA-modified	scaffolds	by	day	7,	which	agrees	with	
the	 observed	 early	 onset	 of	 mineralisation	 in	 the	 presence	 of	 the	 bioceramics.	 The	
presented	 data	 support	 our	 conclusions	 that	 HA	 and	 SrHA	 enhance	 osteoblastic	 cell	
3	
	
	
proliferation	on	polyHIPE	scaffolds	and	promote	early	mineralisation.	
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Introduction	
The	generation	of	fully	functional	and	vascularized	bone	tissue	suitable	for	application	
in	both	load	bearing	and	non-load	bearing	situations	remains	an	unmet	challenge	in	tissue	
engineering.	Progress	requires	a	complex	integration	of	a	number	of	factors,	including,	but	
not	limited	to:	a	scaffold	with	appropriate	morphology,	physical	and	mechanical	properties,	
together	 with	 degradation	 rate,	 to	 permit	 integration	 of	 the	 neo-tissue	 in	 vivo;	 chemical	
and/or	 biological	 factors	 to	 promote	 osteogenesis;	 and	 a	 hierarchy	 of	 pore	 sizes	 that	
promotes	 both	 vascularization	 and	 neo-bone	 formation1.	 Many	 scaffold	 materials	 and	
fabrication	 technologies	 have	 been	 explored,	 including	 supercritical	 foaming	 of	 carbon	
dioxide,	 3D	printing	 of	materials,	 particle	 templating,	 thermally	 induced	phase	 separation	
(TIPS)	and	electrospinning2-5.	No	single	scaffold	type	has	emerged	as	a	generic	substrate	for	
the	 successful	 engineering	 of	 vascularized	 bone	 tissue.	 Amongst	 the	 problems	 associated	
with	 traditional	 methods	 of	 scaffold	 production	 are:	 poor	 interconnectivity	 (hard-sphere	
templating);	 irregular	 and	 poorly	 defined	 morphology	 (TIPS	 scaffolds);	 limited	 cell	
penetration	(electrospun	scaffolds);	lack	of	scaleabililty	(scaffolds	by	3D	printing).	
Highly	 porous	 polymers	with	 a	well-defined	 and	 fully	 interconnected	 porosity	 can	 be	
prepared	readily	by	a	templating	process	involving	a	high	internal	phase	emulsion	(HIPE)6-17.	
The	 HIPE	 is	 created	 with	 a	 droplet	 volume	 fraction	 of	 at	 least	 74%18,	 after	 which	 the	
continuous	 (non-droplet)	 phase	 is	 solidified	 to	 create	 a	 monolithic,	 porous	material.	 The	
resulting	 materials,	 known	 as	 polyHIPEs,	 have	 found	 application	 in	 diverse	 areas	 of	
technology,	 including	 separation/filtration,	 solid	 phase	 synthesis,	 heterogeneous	 catalysis	
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and	 gas	 storage19-26.	 In	 recent	 years,	 polyHIPEs	 have	 undergone	 intense	 investigation	 as	
scaffolds	 for	 cell	 culture	 and	 tissue	 engineering27-49.	 Non-degradable	 styrenic	 polyHIPE	
materials	have	been	shown	to	provide	a	suitable	environment	 for	 the	 in	vitro	 culture	of	a	
wide	 variety	 of	 cell	 types	 in	 3D28,	 30-33,	 35,	 38,	 39.	 These	 scaffolds	 are	 available	 commercially	
under	 the	 tradename	 Alvetex®.	 In	 our	 group,	 we	 have	 devoted	 recent	 efforts	 to	 the	
generation	 of	 degradable	 polyHIPE	 scaffolds	 for	 regenerative	 applications.	 This	 can	 be	
achieved	 by	 the	 photochemically-induced	 step-growth	 polymerisation	 of	 multifunctional	
thiols	and	alkenes	or	alkynes.	In	particular,	commercially	available	multifunctional	acrylates	
are	 convenient	 comonomers	 for	 this	 process37,	 50-52.	 The	 resulting	 degradable	 porous	
scaffolds	have	been	 shown	 to	be	 suitable	 substrates	 for	 the	3D	culture	of	 keratinocytes37	
and	 fibroblasts51.	 	 These	 previous	 studies	 demonstrated	 the	 biocompatibility	 of	 these	
scaffolds	 using	 two	 different	 cell	 types	 and,	 importantly,	 also	 showed	 that	 the	 scaffold	
degradation	 products	 did	 not	 compromise	 cell	 viability.	 	 Significant	 cell	 attachment	 and	
infiltration	into	the	scaffolds	was	demonstrated	up	to	11	days	in	culture.	
Hydroxyapatites	have	been	described	as	bioactive	materials	 that	directly	 regulate	 the	
behaviour	of	both	normal	and	transformed	cells.	 In	particular,	osteoblasts	show	enhanced	
maturation	and	functional	activity	in	the	presence	of	hydroxyapatite53.	Strontium-containing	
hydroxyapatites	support	increased	osteoblast	adhesion,	proliferation	and	viability	in	culture	
when	 compared	 with	 calcium	 hydroxyapatites.	 The	 dissolution	 products,	 apparently	
strontium	 (Sr2+)	 from	 Sr-coated	 implants,	 have	 been	 found	 to	 enhance	 the	 alkaline	
phosphatase	(ALP)	activity	and	 in	vitro	mineralization	ability	of	MSC	cells40.	Strontium	was	
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also	 found	 to	 have	 antiresorptive	 and	 anabolic	 activities	 and	 has	 been	 thought	 to	 have	
potential	interest	for	the	treatment	of	osteoporosis.	More	recently,	Sr2+	has	been	shown	to	
promote	angiogenic	expression	and	to	modify	the	net	positive	charge	on	calcium	phosphate	
nanoparticles54.	
In	 this	 article,	 we	 describe	 the	 preparation	 of	 degradable	 thiol-acrylate	 polyHIPE	
scaffolds	 (Figure	 1)	 loaded	 with	 inorganic	 nanoparticles	 as	 a	 substrate	 for	 the	 culture	 of	
osteoblastic	 cells	 in	 3D.	 Two	 types	 of	 nanoparticle	 were	 used:	 commercially	 available	
hydroxyapatite	(HA);	and	in-house	prepared	strontium-substituted	HA	(SrHA).	The	resulting	
materials	were	subjected	to	thorough	physical,	chemical	and	mechanical	analysis,	and	were	
subsequently	used	for	the	culture	of	osteoblastic	cells	(MG63)	in	3D.	We	note	previous	work	
on	 the	use	of	hydroxyapatite-modified	non-degradable	polystyrene	polyHIPE	materials	 for	
osteoblastic	cell	culture27.	
	
Figure	1.	Monomers	used	to	prepare	the	polyHIPE	scaffolds	by	UV-initiated	thiol-ene	click	
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chemistry.	 Monomer	 1	 is	 trimethylolpropane	 tris(3-mercaptopropionate),	 monomer	 2	 is	
dipentaerythritol	penta-/hexa-acrylate.		
	
Materials	and	Methods	
Materials	
Trimethylolpropane	 tris(3-mercaptopropionate)	 (TMPTMP),	 dipentaerythritol	 penta-
/hexa-acrylate	 (DPEHA),	 1,2-dichloroethane,	 dichloromethane,	 diphenyl	 (2,	 4,	 6-
trimethylbenzoyl)	 phosphine	 oxide/2-hydroxy-2-methylpropiophenone	 blend,	 Pluronic	
F108,	 strontium	hexachloride,	nitric	 acid	and	hydroxyapatite	were	purchased	 from	Sigma-
Aldrich	 and	 used	 without	 modification.	 Hypermer	 B246	 was	 obtained	 from	 Croda	 while	
Alvetex®	3D	 scaffolds	were	purchased	 from	Reinnervate	 Ltd.	 	Complete	media	 for	 culture	
experiments	was	formulated	using	Dulbecco’s	Modified	Eagle	Medium	11995-065	with	10%	
foetal	 bovine	 serum	 and	 1%	 penicillin/streptomycin	 purchased	 from	 Life	 Technologies	
through	Thermo	Fisher	Scientific.	Alkaline	phosphatase	(ALP)	activity	was	determined	using	
an	ALP	assay	kit	(Abcam).	
	
Preparation	of	Strontium-substituted	hydroxyapatite	
Strontium	chloride	solution	was	dissolved	in	250	mL	of	deionised	water	to	a	concentration	
of	 10-3M	 and	 pH	 adjusted	 to	 7.24.	 	 Strontium-substitution	was	 achieved	 by	 adding	 0.5	 g	
hydroxyapatite	per	50	mL	of	 strontium	chloride	 solution	agitated	on	an	orbital	 shaker	 for	
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three	hours.	The	solutions	were	 then	centrifuged	at	3000	rpm	for	 three	minutes	with	 the	
supernatant	 collected	 for	 inductively	 coupled	 plasma	 optical	 emission	 spectrometry	 (ICP-
OES)	 analysis.	 The	 pellet	 itself	 was	 subsequently	 frozen	 and	 freeze-dried	 over	 two	 days.	
Post-sorption	 supernatant	 and	 the	 original	 strontium	 chloride	 solution	were	 acidified	 and	
diluted	 with	 2%	 HNO3	 and	 analysed	 using	 a	 Varian	 730-ES	 axial	 ICP-OES.	 Certified	multi-
element	 solutions	 were	 used	 to	 check	 the	 accuracy	 of	 the	 calibration	 standards	 used.	
Powders	 were	 also	 analysed	 by	 X-ray	 diffraction	 (XRD)	 with	 a	 Bruker	 D8	 Advance	 X-ray	
diffractometer	operating	under	CuKα	radiation	(40	kV,	40	mA)	and	equipped	with	a	LynxEye	
detector.	 Samples	 were	 scanned	 between	 3.5°<2θ<130°	 with	 a	 step	 size	 of	 0.02°	 and	 a	
count	time	of	1.6	seconds	per	step.	Analyses	were	performed	using	the	Bruker	XRD	search	
match	 program	 EVATM	 with	 crystalline	 phases	 identified	 using	 the	 ICCD-JCPDS	 powder	
diffraction	 database.	 Rietveld	 analyses	 were	 performed	 using	 the	 Bruker	 TOPAS	 TM	 V5	
program	to	determine	the	lattice	parameters.		
	
Preparation	of	PolyHIPEs	
The	 oil	 phase	 of	 the	 emulsion	 was	 prepared	 by	 initially	 dissolving	 the	 surfactant	
Hypermer	B246	(0.46	g)	in	7.0mL	of	1,	2-dichloroethane.	TMPTMP	(4.84	g)	and	DPEHA	(3.47	
g)	are	subsequently	added	and	mixed	well	to	create	the	monomer	mixture	(total	volume	14	
mL).	 The	 monomer	 mixture	 is	 then	 transferred	 to	 a	 multi-necked	 flask	 and	 0.7	 mL	 of	
photoinitiator	 (diphenyl	 (2,	 4,	 6-trimethylbenzoyl)	 phosphine	 oxide/2-hydroxy-2-
methylpropiophenone	 blend)	 was	 added.	Water	 was	 added	 dropwise	 while	 an	 overhead	
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stirrer	 attached	 to	 a	 D-paddle	 emulsified	 the	 mixture	 at	 300	 rpm.	 The	 emulsion	 was	
homogenised	 for	 5	 minutes	 from	 the	 addition	 of	 water	 and	 poured	 into	 a	 cylindrical	
polytetrafluoroethylene	mould	with	an	internal	diameter	of	27	mm	and	a	height	of	25	mm	
which	was	then	sandwiched	between	two	glass	plates.	The	mould	was	then	transferred	to	a	
conveyor	belt	travelling	at	3.2	m/s	and	passed	under	a	Heraeus	Fusion	Systems	UV	lamp	to	
initiate	 photopolymerisation.	 The	 sample	was	 passed	 under	 the	 lamp	 four	 times	 (two	 on	
each	side)	with	a	power	output	of	5.7	W/cm2	per	run.	Polymerised	samples	were	removed	
from	their	moulds	and	transferred	to	an	acetone	bath	and	subsequently	washed	in	a	soxhlet	
with	dichloromethane	over	24	hours	to	remove	any	residual	organic	components.		
Incorporation	 of	 hydroxyapatites	 into	 the	 scaffolds	 was	 achieved	 by	 dispersing	 the	
ceramic	 through	the	monomer	phase	prior	 to	emulsification	with	 formulations	outlined	 in	
Table	 1.	 Emulsification	 and	 polymerisation	 were	 carried	 out	 immediately	 to	 minimise	
sedimentation	 and	 agglomeration.	 Samples	 were	 then	 washed	 in	 acetone	 and	
dichloromethane	 in	 a	 Soxhlet	 for	 24h	 each,	 then	 dried	 at	 room	 temperature	 under	
atmospheric	pressure.	
	
Table	1.	Formulations	of	polyHIPE	scaffolds	containing	hydroxyapatite	(HA)	and	strontium-
substituted	hydroxyapatite	(SrHA).		
Samplea	 HA(g)	 SrHA	(g)	 Pluronic	F108	(mg)	
PHP-5HA	 0.7	 -	 7	
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PHP-5SrHA	 -	 0.7	 7	
PHP-10HA	 1.4	 -	 14	
a	PHP:	High	internal	phase	emulsion	templated	polymers	prepared	using	TMPTMP	and	DPEHA	as	co-
monomers,	PHP-5HA:	hydroxyapatite	loading	of	5	wt%	relative	to	volume	of	the	monomer	mixture,	
PHP-5SrHA:	 strontium	 substituted	 hydroxyapatite	 loading	 of	 5	 wt%	 relative	 to	 volume	 of	 the	
monomer	mixture,	PHP-10HA:	hydroxyapatite	loading	of	10	wt%	relative	to	volume	of	the	monomer	
mixture.	
	
Scanning	electron	microscopy	
PolyHIPE	 morphology	 was	 determined	 by	 imaging	 cut	 samples	 using	 a	 FEI	 Nova	
NanoSEM	450	FEGSEM	operating	at	5	kV.	Samples	of	fractured	polyHIPE	were	mounted	on	
aluminium	stubs	fitted	with	adhesive	carbon	fibre	pads	with	the	fractured	surface	face	up.	
Samples	were	coated	with	iridium	using	a	Cressington	208	HR	sputter	coater.	Images	were	
then	 analysed	 using	 ImageJ	 and	 a	 void	 size	 estimate	 was	 determined	 by	 measuring	 the	
diameters	 of	 100	 randomly	 chosen	 voids.	 To	 account	 for	 random	 sectioning	 of	 voids	 a	
statistical	correction	factor	of	2/31/2	was	employed	to	improve	the	accuracy	of	the	result55,	
56.	Energy-dispersive	X-ray	spectroscopy	(EDX)	analysis	of	 incorporated	hydroxyapatite	was	
performed	using	a	Bruker	Quantax	400	x-ray	system.	
	
FTIR	Spectroscopy	
FTIR	spectroscopy	was	used	to	identify	compositional	differences	between	the	native	
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fabricated	polyHIPE	and	the	composite.	Samples	were	pressed	onto	the	sensor	for	a	Thermo	
Scientific	ATR	FTIR	Nicolet	6700	system	and	scanned	16	times	with	a	resolution	of	4	cm-1.	
	
X-ray	photoelectron	spectroscopy	(XPS)	
	 X-ray	 photoelectron	 spectroscopy	 (XPS)	 analysis	was	 performed	using	 an	AXIS	Nova	
spectrometer	(Kratos	Analytical	 Inc.,	Manchester,	UK)	with	a	monochromated	Al	Kα	source	
at	a	power	of	150	W	(15	kV	×	10	mA)	and	a	hemispherical	analyser	operating	 in	the	fixed	
analyser	transmission	mode.	The	total	pressure	in	the	main	vacuum	chamber	during	analysis	
was	typically	between	10-9	and	10-8	mbar.	Survey	spectra	were	acquired	at	a	pass	energy	of	
160	eV.	To	obtain	more	detailed	information	about	chemical	structure,	oxidation	states	etc.,	
high	resolution	spectra	were	recorded	from	individual	peaks	at	40	eV	pass	energy	(yielding	a	
typical	 peak	width	 for	 polymers	 of	 1.0	 eV).	 	 Each	 specimen	was	 analysed	 at	 an	 emission	
angle	of	0°	as	measured	from	the	surface	normal.	Assuming	typical	values	for	the	electron	
attenuation	 length	of	relevant	photoelectrons	the	XPS	analysis	depth	(from	which	95	%	of	
the	detected	signal	originates)	ranges	between	5	and	10	nm	for	a	flat	surface.	As	the	actual	
emission	angle	 is	 ill-defined	 for	 rough	surfaces	and	powders	 (ranging	 from	0º	 to	90º),	 the	
sampling	 depth	 may	 range	 from	 0	 nm	 to	 approximately	 10	 nm.	 Data	 processing	 was	
performed	 using	 CasaXPS	 processing	 software	 version	 2.3.15	 (Casa	 Software	 Ltd.,	
Teignmouth,	 UK).	 All	 elements	 present	 were	 identified	 from	 survey	 spectra.	 The	 atomic	
concentrations	of	the	detected	elements	were	calculated	using	integral	peak	intensities	and	
the	sensitivity	factors	supplied	by	the	manufacturer.	
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Thermogravimetric	Analysis	
Thermogravimetric	 analysis	 was	 performed	 on	 composite	 materials	 in	 order	 to	
determine	 the	 level	 of	 ceramic	 content	 loaded.	 Samples	 were	 loaded	 onto	 an	 alumina	
sample	holder	 and	analysed	using	 the	Netzsch	 STA	449	 F1	 Jupiter	 Simultaneous	 TGA/DSC	
Thermal	Analyser	system.	A	temperature	ramp	rate	of	10	°C/min	was	applied	to	a	maximum	
temperature	of	900	°C	to	facilitate	polymer	burn	off.	Chamber	conditions	were	controlled	by	
flowing	nitrogen	through	at	a	 rate	of	40	mL/min.	Measurements	were	carried	out	using	a	
Type	 S	DSC	 sensor.	Mass	 loss	 for	 each	 sample	was	 then	determined	as	 a	percentage	and	
averaged	across	three	trials.	
	
Scaffold	Preparation	
Scaffolds	 used	 for	 culture	 of	 MG63	 cells	 were	 prepared	 by	 cutting	 polymerised	
monoliths	with	 a	 Leica	VT1000S	 vibrating	microtome	at	 a	 thickness	 of	 200	µm.	A	 15	mm	
bore	was	 used	 to	 excise	 circular	 scaffold	 samples	 for	 in	 vitro	 culture.	 Samples	were	 then	
dipped	 in	 ethanol	 and	water	 and	 dried	 on	 filter	 paper	 to	 flatten.	 PolyHIPE	 scaffold	 discs	
were	 then	 mounted	 in	 well	 inserts	 in	 a	 biosafety	 hood	 and	 placed	 into	 a	 6-well	 plate.	
Sterilisation	of	scaffolds	was	performed	by	washing	in	80%	ethanol	thrice	for	15	minutes.	
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Compression	Testing	
Cylindrical	 scaffold	 sections	 with	 a	 diameter	 of	 5	 mm	 and	 a	 height	 of	 2	 mm	were	
subjected	to	uniaxial	compression	 in	an	 Instron	5500R	with	a	10	N	 load	cell.	A	cross	head	
speed	 of	 0.25	mm/min	was	 applied	 until	 12.5%	 sample	 deformation	 had	 been	 achieved.	
Data	was	collected	using	BlueHill3	software	version	3.3	and	analysed	in	MATLAB.	The	linear	
region	of	the	load-deflection	curve	was	fitted	with	a	regression	curve	(R2>0.99)	and	used	to	
calculate	 the	strain	of	deformation.	 Load	at	10%	specimen	deformation	or	 the	yield	point	
(whichever	was	 lower)	was	then	used	to	calculate	the	strength.	Compressive	strength	was	
determined	 by	 dividing	 the	 load	 by	 the	 initial	 cross-sectional	 area	 of	 the	 sample.	 The	
compressive	modulus	was	determined	by	reading	the	load	and	deformation	at	the	steepest	
straight	line	portion	of	the	curve	and	evaluating	using	Equation	[1].	
	
𝐸! = !"!" 		 	 	 	 	 	 [1]		
where,	Ec	is	the	modulus	of	elasticity	in	compression	(Pa),	W	is	the	load	(N),	A	is	the	initial	
cross-sectional	 area	 (m2)	 and	 D	 is	 the	 deformation	 (m).	 Statistical	 differences	 were	
determined	by	applying	a	one-way	ANOVA	with	the	Holm-Sidak	approach	in	comparing	the	
difference	in	sample	means.	
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Cell	Culture	and	histology	
Scaffolds	 were	 pre-treated	 by	 washing	 in	 ethanol	 followed	 by	 phosphate	 buffered	
saline	and	complete	media	and	allowed	to	incubate	overnight	at	37	°C,	5%	pCO2.	Media	was	
then	 replaced	 to	half	of	 the	 total	 culture	volume	 (5mL).	MG63	osteosarcoma	cells	 (ATCC)	
were	seeded	at	a	density	of	0.5x106	cells	per	scaffold	to	the	scaffold	surface	and	incubated	
overnight	to	allow	for	cell	attachment.	Media	was	then	topped	up	to	10	mL	and	maintained	
for	the	remainder	of	the	culture	period	with	a	replacement	every	2-3	days.	Scaffolds	were	
then	harvested	at	days	7,	14	and	21	for	fixing	with	formalin	and	embedding	in	paraffin	wax	
processed	 using	 the	 Leica	 Peloris	 rapid	 tissue	 processor.	 Cross-sections	 10μm	 thick	 were	
mounted	on	 slides	 and	 stained.	 Processing	 for	 von	Kossa’s	 (VK)	 involved	bringing	paraffin	
sections	to	water	and	placed	 in	1.5%	silver	nitrate	solution	and	 left	 in	strong	 light	 for	one	
hour.	 Slides	were	 then	washed	 in	water	 and	 counterstained	with	nuclear	 fast	 red	 for	 ten	
minutes.	Additional	 slides	 in	 paraffin	were	placed	 in	 0.5%	Alizarin	Red	 S	 (AR)	 solution	 for	
one	hour	and	rinsed	in	1%	sodium	hydroxide	for	5	seconds.	Slides	were	then	dehydrated	in	
absolute	ethanol,	cleared	in	xylene	and	mounted.	Slides	were	imaged	using	a	Nikon	Eclipse	
TS100	microscope	in	bright-field	and	captured	using	Q-Capture	Pro	7.	
	
Bradford	Assay	
Scaffolds	were	removed	from	their	inserts,	washed	three	times	in	cold,	sterile	PBS,	and	
cut	into	small	(~	1	mm)	pieces	with	sterile	scissors.	The	scaffold	pieces	were	placed	in	a	pre-
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cooled	Eppendorf	tube,	and	500	µl	radioimmunoprecipitation	assay	(RIPA)	buffer	containing	
5	 µl	 protease	 cocktail	 inhibitor	 added.	 The	 scaffolds	 were	 then	 incubated	 on	 ice	 for	 15	
minutes,	with	vortexing	every	3	minutes	for	30	seconds	in	order	to	dislodge	the	cells	from	
the	scaffold.	Samples	were	then	centrifuged	at	12,000	rpm	for	15	minutes	at	4	oC	in	order	to	
pellet	the	scaffold	and	cell	debris.	The	supernatant	was	then	removed,	placed	in	a	fresh	pre-
cooled	Eppendorf	tube,	and	diluted	1:40	in	PBS.	
A	bovine	serum	albumin	(BSA)	protein	ladder	was	prepared	in	order	to	give	9	standards	
ranging	in	concentration	from	2	mgml-1	to	0	mgml-1.	10	µl	of	each	sample	or	standard	was	
pipetted	into	a	flat-bottom	96	well	plate.	300	µl	Coomassie	Plus	Reagent	was	then	added	to	
each	 well	 and	 mixed	 thoroughly.	 The	 plate	 was	 then	 incubated	 for	 10	 minutes	 at	 room	
temperature,	 and	 the	 absorbance	 read	 at	 595	 nm	 using	 a	 Thermo	 Scientific	 Multiskan	
Spectrum	plate	reader.	The	Bradford	assay	was	performed	in	triplicate	for	each	material	and	
culture	 time	 tested.	 The	 mean	 and	 standard	 deviation	 were	 determined	 and	 a	 two-way	
analysis	 of	 variance	 (ANOVA).	 A	 Tukey	 post-hoc	 test	 for	 multiple	 comparisons	 was	
performed	with	p	<	0.05	to	determine	statistical	differences.	
	
Alkaline	Phosphatase	(ALP)	Assay	
Scaffolds	were	prepared	for	ALP	assay	using	the	same	method	as	described	above	for	
Bradford	assay,	with	ALP	assay	buffer	replacing	RIPA	buffer.	The	obtained	supernatant	was	
collected	and	placed	in	a	fresh	pre-cooled	Eppendorf	tube.	
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120	 µl	 standard	 solutions	 of	 para-nitrophenylphosphate	 (pNPP),	 with	 concentrations	
ranging	from	0	nmol	well-1	to	20	nmol	well-1,	were	added	to	2	wells	of	a	96	well	plate,	and	
80	µl	of	each	samples	added	to	a	further	3	wells.	50	µl	of	a	5	mM	pNPP	solutions	was	then	
added	to	each	sample	well,	followed	by	the	addition	of	10	µl	ALP	enzyme	to	each	standard	
well.	The	plate	was	then	protected	from	light,	and	incubated	at	25	oC	for	1	hour.	10	µl	stop	
solution	was	 then	 added	 to	 each	well,	 and	 the	 absorbance	measured	 at	 405	 nm	 using	 a	
Thermo	Scientific	Multiskan	Spectrum	plate	 reader.	 The	Bradford	assay	was	performed	 in	
triplicate	 for	 each	 material	 and	 culture	 time	 tested.	 Mean	 and	 standard	 deviation	 were	
determined,	 a	 two-way	 ANOVA	 and	 Tukey	 post-hoc	 test	 were	 applied	 to	 determine	
statistical	significance.	
	
Results	
Strontium	substitution	into	hydroxyapatite	
Hydroxyapatite	was	added	to	a	solution	of	strontium	chloride	and	agitated	to	facilitate	
adsorption	and	ion	exchange.	ICP-OES	and	XRD	were	used	to	evaluate	the	incorporation	of	
strontium.	 Ion	 concentrations	 of	 Sr2+	 and	 Ca2+	 were	 compared	 between	 the	 original	
strontium	chloride	 solution	 and	 the	post-sorption	 supernatant.	Approximately	 40%	of	 the	
strontium	initially	present	in	solution	is	removed	with	the	hydroxyapatite.	
	
Table	2.	ICP-OES	and	XRD	analysis	of	Sr-modified	hydroxyapatite	nanoparticles	
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	 ICP-OES	(mM)	 	 Lattice	Parameters	(A)	
Sample	 Sr	 Ca	 Powder	Sample	 a	 c	
Strontium	
Chloride	solution	
0.90	 3.0x10-3	 HA	 9.424±0.001	 6.883±0.001	
Supernatant	 0.53	 0.96	 Sr-HA	 9.429±0.001	 6.890±0.001	
	
	 XRD	 patterns	 of	 the	 original	 hydroxyapatite	 powder	 sample	 and	 the	 post-sorption	
hydroxyapatite	 were	 obtained	 and	 a	 Rietveld	 refinement	 applied	 (Figure	 S1).	 Lattice	
parameters	 obtained	 in	 the	 post-sorption	 sample	 are	 larger	 than	 the	 unaltered	
hydroxyapatite	 by	more	 than	 three	 standard	 deviations.	 This	 indicates	 that	 it	 is	 probable	
that	 strontium	has	been	 incorporated	 through	 substitution	 into	 the	hydroxyapatite	 lattice	
structure.	
	
Morphology	of	polyHIPE	scaffolds	
PolyHIPE	scaffolds	with	a	nominal	porosity	of	90%	were	prepared	using	the	monomers	
TMPTMP	 and	 DPEHA.	 Hydroxyapatite	 and	 Sr-modified	 hydroxyapatite	 nanoparticles	 were	
incorporated	by	mechanical	dispersion	through	the	monomer	phase	prior	to	emulsification	
and	 curing.	A	homogeneous	distribution	of	particles	was	obtained	by	 stirring	 the	 solution	
with	a	magnetic	stirrer	at	500	rpm	for	one	hour.	 	The	amount	of	hydroxyapatite	added	to	
each	 sample	 was	 determined	 as	 a	 function	 of	 the	 total	 monomer	 volume	 (14	 mL)	 and	
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partially	 stabilised	 with	 Pluronic	 F108.	 Hydroxyapatite	 incorporation	 into	 the	 polyHIPE	
scaffold	was	evaluated	as	a	 function	of	concentration	between	0-10%	with	 representative	
areas	depicted	in	Figure	2.	Morphological	features	which	hallmark	polyHIPE	materials	such	
as	 rounded	 interior	 and	 highly	 interconnected	 pores	 are	 evident	 in	 all	 materials.	 As	 the	
concentration	 of	 hydroxyapatite	 in	 the	 formulation	 is	 increased,	 the	 ceramic	 becomes	
visible	on	the	scaffold	interior	and	covers	an	increasing	area	of	the	available	surface.	From	
Figure	2,	there	 is	very	 little	difference	 in	the	morphology	of	the	scaffolds	produced	with	0	
wt%	hydroxyapatite	and	those	with	5	wt%	hydroxyapatite.	At	higher	concentrations,	there	
appears	 to	 be	 a	 marked	 destabilising	 effect	 leading	 to	 extremely	 large	 internal	 voids.	
Detailed	 characterisation	 of	morphology	 and	 porosity	 of	 the	 parent	 (hydroxyapatite-free)	
scaffolds	has	been	presented	in	previous	papers37,	50,	51.	
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Figure	2.	Scanning	electron	microscope	images	of	scaffolds	at	500x	(A,	B,	C)	and	5000x	(D,	E,	
F)	magnification.	A,D	–	PolyHIPE	scaffold,	B,E	–	PolyHIPE	scaffold	+	5	wt%	hydroxyapatite,	
(D,F)	–	PolyHIPE	scaffold	+	10	wt%	hydroxyapatite.	Scale	bars	represent	100	μm	and	10	μm	
for	 low	and	high	magnification	 respectively.	G	–Void	 size	distribution	of	polyHIPE	 scaffold	
materials	 based	 on	 the	 percentage	 of	 voids	 with	 a	 given	 diameter.	 Blue	 shows	 the	
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distribution	 for	 the	 native	 polyHIPE	 scaffold,	 in	 red	 is	 the	 distribution	 for	 the	 PHP-5HA	
scaffold	and	in	green	is	the	distribution	for	the	PHP-10HA	scaffold.	
	
	 A	 key	 comparator	 used	 to	 evaluate	 polyHIPE	 morphology	 is	 the	 average	 void	
diameter	 which	 was	 determined	 by	 measuring	 100	 random	 representative	 voids	 and	
applying	a	statistical	correction	factor.	A	mean	void	diameter	of	58±23	µm	was	attained	for	
the	native	polyHIPE	structure	and	a	mean	void	diameter	of	57±28	µm	was	determined	for	
PHP-5HA.	 The	 distribution	 of	 the	 void	 sizes	 is	 described	 in	 Figure	 2	 with	 no	 substantial	
differences	 observable	 between	 PHP	 and	 PHP-5HA.	 At	 10	wt%	 hydroxyapatite,	 the	mean	
void	 diameter	 becomes	 99±66	 µm	 and	 significant	 elongation	 of	 the	 upper	 tail	 occurs,	
indicative	of	a	reduction	in	HIPE	stability.	
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Figure	 3.	 Energy	 dispersive	 x-ray	 spectroscopy	 elemental	 mapping	 of	 polyHIPE	 materials	
containing	10	wt%	hydroxyapatite.	A	–	area	map	highlighting	the	presence	of	calcium	shown	
in	red,	B	–	area	map	highlighting	the	presence	of	phosphorus	shown	in	green,	C	–	overlay	
map	of	calcium	and	phosphorus,	D	–	SEM	image	of	scanned	region.	
	
	 EDX	analysis	of	 the	polyHIPE	highlights	 the	 spread	of	nanoparticles	 in	 the	polymer	
matrix.	The	high	level	of	concordance	between	the	calcium	and	phosphate	signals	suggests	
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the	presence	of	the	added	hydroxyapatite.	Hydroxyapatite	nanoparticles	are	well	dispersed	
through	the	matrix	with	some	larger	agglomerations.	
	
FTIR	Spectroscopy	
Incorporation	of	hydroxyapatite	into	the	polymer	scaffold	can	be	shown	through	FTIR	
spectroscopy.	Hydroxyapatite	analysed	as-supplied	produces	a	double	peak	at	569	cm-1	and	
604	cm-1	as	well	as	a	strong	peak	with	a	shoulder	1030	cm-1	which	correspond	to	vibrational	
modes	in	the	phosphate	moiety.	The	polymer	matrix	presents	with	a	sharp	peak	at	1730	cm-
1	corresponding	to	the	C=O	stretch	as	well	as	a	C-H	stretch	at	2853	cm-1.	In	the	composite,	
the	peaks	from	the	phosphate	group	are	readily	visible	as	well	as	the	absorptions	from	the	
polymer	phase.	The	appearance	of	these	absorbance	bands	in	the	phosphate	region	which	
do	not	 appear	 in	 the	 native	 polymer	 demonstrate	 the	 incorporation	 of	 hydroxyapatite	 to	
form	a	composite.		
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Figure	4.	FTIR	spectra	of	the	(a)	hydroxyapatite	nanoparticles,	(b)	polyHIPE	scaffold	and	(c)	
polyHIPE	+	5	wt%	hydroxyapatite	composite	scaffold	
	
X-ray	photoelectron	spectroscopy	
Compositional	 analysis	 of	 ceramic	 powders	 as	 well	 as	 polymer-ceramic	 composites	
was	carried	out	using	XPS	(Table	3).	Between	PHP-5HA	and	PHP-10HA,	the	ratio	of	oxygen	to	
carbon	 increased	 due	 to	 the	 further	 addition	 of	 phosphate.	 XPS	 also	 highlights	 the	
incorporation	 of	 strontium	 into	 hydroxyapatite	 as	 evidenced	 by	 the	 comparison	 between	
strontium	substituted	hydroxyapatite	powder	(SrHA)	and	hydroxyapatite	powder	as	well	as	
PHP-5SrHA	 and	 PHP-5HA.	 Furthermore,	 the	 calcium	 to	 phosphate	 ratio	 in	 strontium	
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substituted	hydroxyapatite	 is	 reduced	as	a	 consequence	of	 the	 replacement	of	 calcium	 in	
the	lattice	with	strontium.	
	
Table	3.	XPS	results	on	polyHIPE	composite	materials	(atomic	concentrations	in	%)	
Samplea	 C	 O	 S	 Ca	 P	 Sr	 O/C	 Ca/P	
HA	 13.3	 54.7	 -	 18.7	 12.3	 -	 4.1	 1.5	
SrHA	 14.0	 54.4	 -	 17.7	 12.4	 1.4	 3.9	 1.4	
PHP-5HA	 79.0	 17.5	 2.3	 0.6	 0.6	 -	 0.2	 1.1	
PHP-5SrHA	 83.3	 14.6	 1.4	 0.3	 0.3	 0.1	 0.2	 0.8	
PHP-10HA	 74.3	 20.9	 3.0	 1.0	 0.8	 -	 0.3	 1.2	
a	HA:	native	hydroxyapatite,	SrHA:	strontium	substituted	hydroxyapatite	
	
Thermogravimetric	analysis	of	polyHIPE	composites	
Quantification	 of	 ceramic	 loading	 into	 the	 polymer	 matrices	 was	 performed	 using	
thermogravimetric	 analysis	 (Figure	 S2).	 Polymer-composite	 samples	 were	 subjected	 to	
elevated	 temperatures	 in	 order	 to	 remove	 organic	 content	 and	 determine	 the	 ceramic	
composition	 of	 the	 composite.	 At	 a	 loading	 of	 5	 wt%	 hydroxyapatite,	 the	 mean	 mass	
attributable	to	the	ceramic	was	4.6%	of	the	original	mass.	Increasing	the	loading	to	10wt%	
hydroxyapatite	resulted	in	a	mean	attributable	mass	of	10.4	wt%	of	the	polymer	composite.	
This	demonstrates	that	hydroxyapatite	added	prior	the	polymerisation	can	be	incorporated	
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into	a	polymer-ceramic	 composite	and	 that	 the	 ceramic	 component	 remains	after	 several	
washing	steps.	
	
Table	4.	Mass	loss	of	polymer-ceramic	composites	under	thermal	degradation	
Samplea	 Mass	loss	(%)	
PHP	 100	±	0.5	
PHP-5HA	 95.4	±	2.4	
PHP-10HA	 89.6	±	0.7	
a	sample	key	as	for	Table	1.	Results	presented	as	mean	±	standard	deviation	(N=3).	
	
Compression	Testing	
Mechanical	 properties	 of	 cellular	 hydroxyapatite	 composites	 were	 evaluated	 under	
uniaxial	compression	to	determine	their	compressive	strength	and	modulus	 (Table	5).	The	
compressive	strength	of	PHP-10HA	is	significantly	greater	than	PHP	and	PHP-5HA	(F	=21.40,	
P	<	0.0001).	
	
Table	 5.	 Mechanical	 properties	 of	 hydroxyapatite	 porous	 scaffold	 constructs	 under	
compression.	
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Samplea	 Number	of	Samples	
Tested	
Compressive	
Strength	(kPa)	
Compressive	
Modulus	(MPa)	
PHP	 7	 148	±	11	 2.58	±	0.36	
PHP-5HA	 10	 153	±	20	 2.34	±	0.25	
PHP-10HA	 6	 216	±	32	 2.52	±	0.32	
a	Sample	key	as	in	Table	1.	Results	processed	with	1.25	standard	deviation	of	error.	
	
	 The	effects	of	the	addition	of	hydroxyapatite	are	to	some	extent	obfuscated	by	the	
high	degree	of	heterogeneity	in	the	scaffold	mechanical	properties	which	is	reflected	in	the	
magnitude	of	 the	standard	deviation	of	 the	sample	set.	This	heterogeneity	 in	part	reflects	
the	distribution	of	void	diameters	within	 the	porous	scaffold	which	results	 in	uneven	 load	
distribution	and	varies	between	 samples.	 Larger	pore	diameters	within	 the	 scaffold	mean	
that	local	stresses	within	the	matrix	will	be	greater	and	can	influence	the	spread	of	results.	
Moreover,	 the	method	employed	 for	 incorporating	 hydroxyapatite	 at	 high	 concentrations	
appears	to	compound	these	influences	by	producing	a	very	wide	void	diameter	distribution	
and	 a	 large	 mean	 void	 diameter.	 Hence,	 potential	 mechanical	 benefits	 provided	 by	 the	
incorporation	 of	 hydroxyapatite	 are	 also	 dependent	 on	 the	 morphology	 of	 the	 porous	
scaffold.	
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Cell	Culture	
Biocompatibility	of	scaffold	constructs	was	evaluated	through	 in	vitro	culture	of	MG63	
osteosarcoma	cells.	Scaffolds	were	sectioned	into	200	µm	thick	slices	and	seeded	with	cells.	
Alvetex®	3D	scaffolds	were	selected	as	the	control	environment	against	the	native	polyHIPE	
and	composite	versions.	Alvetex®	scaffolds	present	a	porous	three-dimensional	polystyrene	
network	with	an	average	void	size	of	30-40	µm	and	were	treated	under	the	same	conditions	
as	 synthesised	 materials.	 Composite	 polyHIPEs	 were	 produced	 with	 either	 5wt%	
hydroxyapatite	or	5wt%	strontium-substituted	hydroxyapatite	to	reduce	the	impact	of	large	
void	 diameters	 at	 higher	 incorporation	 concentrations	 on	 cell	 phenotype.	 Due	 to	 oblique	
cutting	of	 sections,	 PHP-5SrHA	 samples	 appear	 thicker	 than	other	 scaffold	 sections	which	
are	approximately	200	µm	in	height.	Distribution	of	cells	and	degree	of	mineralisation	over	
the	period	was	determined	through	histological	techniques	(Figure	5).	
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Figure	5.	Histologically	stained	sections	of	scaffolds	cultured	for	7	days	(A,	C,	E,	G)	and	21	
days	(B,	D,	F,	H);	A,B	–	Alvetex®,	C,D	–	PolyHIPE,	E,F	–	PolyHIPE	+5wt%	hydroxyapatite,	G,H	–	
PolyHIPE	+	5wt%	strontium-substituted	hydroxyapatite.	Von	Kossa’s	stain	(black	colour)	was	
used	to	indicate	the	presence	hydroxyapatite	as	well	as	mineralisation	(examples	indicated	
by	arrows);	cells	are	counterstained	with	nuclear	fast	red.	Scale	bars	represent	100	μm.	
	
	 Over	 the	 culture	 period,	 cells	 were	 able	 to	 migrate	 through	 and	 populate	 the	
scaffolds.	 	 Cells	 migrate	 from	 the	 upper	 open	 surface	 to	 the	 lower	 open	 surface	 before	
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dividing	and	spreading	to	form	a	continuous	layer	and	filling	the	remaining	free	space	within	
the	 scaffold.	 All	 scaffolds	 are	 capable	 of	 supporting	 vigorous	 growth	 of	MG63	 cells.	 Von	
Kossa	staining,	which	detects	phosphate,	was	used	to	investigate	mineralization.	The	extent	
of	von	Kossa	staining	(black	colour	in	Figure	5)	is	variable	across	the	scaffolds.	It	should	be	
noted	that	scaffolds	containing	HA	and	SrHA	will	be	positive	for	von	Kossa	due	to	inorganic	
phosphates	 present	 in	 the	 hydroxyapatite	 coating	 on	 the	 scaffold	 surface.	 Consequently,	
ceramic-modified	 scaffolds	 at	 day	 7,	 particularly	 PHP-5HA,	 show	 widespread	 background	
staining	throughout.	Nonetheless,	evidence	of	larger	phosphate	deposits	possibly	indicating	
early	onset	of	mineralization	can	be	seen,	most	notably	in	the	SrHA	sample	(arrows	in	Figure	
5E,	G).	At	day	21,	the	formation	of	significant	quantities	of	large,	von	Kossa	positive	nodules	
is	 apparent	 (Figure	 5	 F,	 H),	 suggesting	 that	 mineralisation	 has	 progressed	 further.	 The	
nodules	on	sample	PHP-5SrHA	are	more	numerous	than	those	observed	in	PHP-5HA	despite	
being	 smaller	 in	 size.	 Furthermore,	 the	 background	 scaffold	 staining	 caused	 by	
hydroxyapatite	 is	 largely	 absent,	 indicating	 dissolution/resorption	 of	 HA	 and	 SrHA.	 The	
scaffolds	without	HA	or	SrHA	show	little	evidence	of	mineralization	(Figure	5	B,	D)	
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Figure	 6.	 Histologically	 stained	 sections	 of	 PHP-5HA	 (A,	 C,	 E)	 and	 PHP-5SrHA	 (B,	 D,	 F)	
scaffolds;	A,B	–	Day	7	of	culture,	C,D	–	Day	14	of	culture,	E,F	–	Day	21	of	culture.	An	Alizarin	
Red	stain	was	used	to	indicate	the	presence	hydroxyapatite	as	well	as	mineralisation	in	red	
(examples	indicated	by	arrows).	Scale	bars	represent	100	μm.	
	
The	 Alizarin	 Red	 (AR)	 stain	 was	 also	 applied	 in	 order	 to	 identify	 the	 progress	 of	
mineralisation	within	the	scaffolds	during	the	culture	period	(Figure	6).	AR	staining	was	used	
because	there	is	less	interference	from	the	scaffold	in	comparison	to	von	Kossa	in	terms	of	
stain	 uptake	 and	 it	 is	more	 sensitive	 to	 early	 time	 point	mineralisation.	 Furthermore,	 by	
implementing	 both	 von	 Kossa	 and	 AR	 staining,	 calcium	 and	 phosphate	 staining	 can	 be	
compared	for	overlap	to	indicate	the	presence	of	hydroxyapatite	or	calcium	phosphate.	It	is	
evident	 that	 over	 time	 the	 number	 and	 size	 of	 calcium-staining	 regions	 increases	 in	 both	
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PHP-5HA	and	PHP-5SrHA.	Strontium-substituted	hydroxyapatite	appears	to	have	the	added	
benefit	of	instigating	an	earlier	onset	of	mineralisation	than	hydroxyapatite.	
Cell	 adhesion	 and	 proliferation	 on	 scaffolds	 was	 assessed	 semi-quantitatively	 by	 a	
Bradford	 total	 protein	 assay	 (Figure	 7).	 Statistically	 significant	 differences	 were	 observed	
between	 Alvetex	 and	 PHP-5HA	 and	 PHP-5SrHA	 (p	 <	 0.01)	 at	 day	 7	 and	 at	 Day	 21	 (p	 <	
0.0001).	At	day	21,	a	statistically	significant	difference	was	noted	between	Alvetex	and	PHP-
5HA	 and	 PHP-5SrHA	 and	 between	 PHP	 and	 PHP-5HA,	 PHP-5SrHA	 scaffolds	 (p	 <	 0.0001).		
Strontium-modified	hydroxyapatite	and,	to	a	 lesser	extent,	hydroxyapatite	both	result	 in	a	
significant	increase	in	cell	adhesion	and/or	proliferation	at	day	7,	compared	to	Alvetex	and	
unmodified	polyHIPE.	These	results	are	in	agreement	with	histology	data	(Figure	5).	At	later	
timepoints	this	trend	is	replicated,	and	is	particularly	evident	at	day	21	where	total	protein	
levels	 are	 very	much	 higher	 on	 the	 bioceramic-modified	 scaffolds	 compared	 to	 those	 on	
unmodified	 scaffolds.	 Cell	 adhesion/proliferation	 is	 consistently	 higher	 on	 SrHA	 scaffolds	
than	on	those	containing	HA,	in	agreement	with	data	on	the	growth	of	osteoprecursor	cells	
on	HA-	and	SrHA-coated	surfaces57.		
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Figure	7.	Total	protein	determination	on	scaffolds	by	Bradford	assay	at	day	7,	14	and	21	of	
culture	for	each	scaffold	type	presented	as	mean	±	sd	(n	=	3).		
	
Alkaline	phosphatase	(ALP)	activity	of	MG63	osteoblastic	cells	cultured	on	scaffolds	was	
investigated	at	days	7,	14	and	21.	ALP	is	an	early	osteoblastic	marker58,	the	expression	and	
activity	 of	 which	 has	 been	 shown	 to	 reduce	 as	 cells	 mature	 and	mineralization	 begins59.	
Normalized	ALP	expression	(Figure	8)	was	found	to	be	highest	at	the	earliest	timepoint	(day	
7)	 for	each	 scaffold	 type.	A	 statistically	 significant	difference	was	observed	 in	ALP	activity	
between	Alvetex	 and	 all	 other	 scaffold	 types	 (p	 <	 0.0001)	 at	 day	 7	 of	 culture.	 Significant	
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differences	were	also	observed	between	PHP	and	loaded	scaffolds,	PHP-5HA	and	PHP-5SrHA	
(p	<	0.0001	and	p	<	0.001	respectively).	Furthermore,	ALP	expression	at	each	timepoint	was	
notably	 higher	 on	 unmodified	 scaffolds	 compared	 to	 those	 containing	 HA	 or	 SrHA.	 This	
suggests	a	downregulation	of	ALP	and/or	loss	of	ALP	activity	in	the	presence	of	HA	or	SrHA.	
	
Figure	8.	ALP	expression	per	µg	of	total	protein	for	MG63	cells	cultured	on	scaffolds	at	day	
7,	14	and	21	presented	as	mean	±	sd	(n	=	3).	
	
Discussion	
Porous	polymer	scaffolds	made	through	the	emulsion	templating	process	confer	many	
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advantages	 such	 as	 degradability,	 surface	 functionalisation	 and	 flexibility	 in	 chemistry.	 In	
tuning	 the	 properties	 of	 the	 emulsion-templated	 scaffold,	 a	 composite	 approach	 can	 be	
adopted	which	opens	another	avenue	for	tailoring	of	material	properties.	Hydroxyapatite	is	
often	 incorporated	 into	 scaffolds	 used	 in	 bone	 tissue	 engineering	 applications	 as	 it	 bears	
chemical	similarity	with	bone	mineral.	The	chemical	composition	of	the	polyHIPE	(Figure	1)	
was	based	on	a	highly	crosslinked	acrylate-thiol	system	previously	described	with	a	tensile	
Young’s	modulus	of	19MPa37.	The	relatively	high	modulus	of	this	material	lent	itself	towards	
bone	tissue	engineering	and	was	further	adapted	with	the	incorporation	of	hydroxyapatite.	
Furthermore,	strontium	has	been	increasingly	recognised	as	a	potent	adjuvant	to	influence	
bone	 formation	with	 and	without	 hydroxyapatite	 and	 has	 been	 linked	with	 promotion	 of	
osteoblast	activity	while	inhibiting	osteoclasts.		
Strontium	 ions	 were	 substituted	 for	 calcium	 in	 the	 hydroxyapatite	 lattice	 structure	
through	a	sorption	and	ion	exchange	process.	Based	on	the	ICP-OES	analysis,	a	reduction	in	
the	 strontium	 concentration	 in	 solution	 was	 accompanied	 by	 an	 increase	 in	 the	 calcium	
concentration	 of	 the	 supernatant.	 Given	 that	 the	 lattice	 structure	 simultaneously	
underwent	a	minor	expansion,	strontium	is	not	merely	adsorbed	on	the	surface	of	particles,	
but	has	been	 integrated	 into	the	crystal	structure	of	the	hydroxyapatite.	The	minor	 lattice	
expansion	reflects	 the	 larger	size	of	 the	strontium	 ion	compared	to	calcium.	Furthermore,	
apart	 from	hydroxyapatite	and	 trace	calcium	phosphate,	no	other	 crystalline	phases	were	
identified,	suggesting	that	no	new	crystalline	phases	have	 formed	 indicating	 incorporation	
of	 strontium	 by	 calcium	 substitution.	 This	 is	 supported	 by	 XPS	 of	 the	 supplied	
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hydroxyapatite	 in	 comparison	 with	 strontium	 substituted	 hydroxyapatite.	 The	 atomic	
concentration	of	calcium	is	observed	to	decrease	slightly	in	the	SrHA	sample.	Notably,	when	
the	 sum	 of	 the	 atomic	 concentration	 of	 calcium	 and	 strontium	 is	 divided	 by	 the	
concentration	of	phosphate	a	Ca/P	ratio	is	obtained	which	is	equal	to	the	Ca/P	ratio	of	the	
supplied	hydroxyapatite.	By	substituting	strontium	into	the	hydroxyapatite	crystal	structure,	
the	benefits	of	hydroxyapatite	are	preserved	while	simultaneously	providing	trace	amounts	
of	strontium	to	aid	in	mineralisation.	
Scaffolds	were	produced	by	emulsion	templating	monomer	solutions	containing	varying	
ceramic	content.	At	low	ceramic	concentrations	(<5	wt%),	there	is	negligible	impact	on	the	
overall	morphology	and	distribution	of	voids.	However,	at	higher	concentrations	there	is	a	
visible	destabilising	effect	on	the	emulsion	as	at	10	wt%	concentration	very	large	voids	are	
produced.	Emulsion	destabilisation	broadens	the	pore	distribution	by	introducing	a	greater	
number	of	large	voids	(>100	µm).	Further	increases	in	hydroxyapatite	concentration	may	be	
of	 use	 in	 facilitating	 larger	 void	 diameters	 desired	 in	 in	 vivo	 scaffold	 implants	 while	 also	
providing	more	 hydroxyapatite.	 Hydroxyapatite	 is	well	 represented	 on	 the	 surface	 of	 the	
scaffold	 interior	as	 indicated	by	the	rough	texturing	observable	under	SEM.	There	is	a	fine	
and	even	distribution	of	nanoparticles	through	the	matrix	as	well	as	 larger	agglomerations	
which	are	stable	through	the	washing	process.	
Analysis	 of	 fabricated	 scaffolds	 by	 FTIR	 showed	 the	 presence	 of	 sharp	 phosphate	
absorbance	bands	indicative	of	hydroxyapatite.	In	particular,	the	appearance	of	the	double	
peak	 at	 569	 cm-1	 and	 604	 cm-1	 strongly	 correlates	 with	 native	 hydroxyapatite.	 Calcium,	
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phosphate	and	strontium	are	detectable	in	composite	scaffolds	subjected	to	XPS.	Compared	
with	the	ceramic	powders,	the	Ca/P	ratio	is	reduced	which	implies	partial	loss	of	calcium.	As	
the	 concentration	 of	 hydroxyapatite	 is	 increased,	 the	O/C	 ratio	 also	 increases	 due	 to	 the	
presence	 of	 phosphate.	 To	 confirm	 the	 loading	 of	 hydroxyapatite	 into	 the	 scaffolds,	
thermogravimetric	 analysis	 in	 a	 nitrogen	 environment	 was	 performed.	 With	 good	
agreement	 between	 the	 loaded	 amount	 and	 the	mass	 remaining	 after	 burn-off,	 scaffolds	
are	capable	of	retaining	varying	degrees	of	ceramic.	
Mechanical	 responses	 of	 composite	 scaffolds	 were	 determined	 through	 uniaxial	
compression	 testing.	No	 significant	 differences	were	 observed	 in	 data	when	 an	 allowable	
error	of	2.8	standard	deviations	of	the	mean	was	applied.	To	reduce	the	 impact	of	outlier	
samples,	 an	 allowable	 error	 of	 1.25	 standard	 deviations	 was	 chosen.	 The	 compressive	
strength	of	PHP-10HA	was	found	to	be	significantly	greater	than	PHP	and	PHP-5HA	(F=21.40,	
P	<	0.0001).	This	demonstrates	that	mean	compressive	strength	of	the	composites	increases	
with	hydroxyapatite	loading,	while	modulus	is	largely	unaffected.	
Of	 particular	 interest	 in	 the	 design	 of	 scaffolds	 for	 in	 situ	 tissue	 engineering	 is	 the	
matching	of	the	mechanical	properties	of	the	scaffold	to	that	of	the	native	tissue	as	 it	can	
have	impacts	on	the	local	phenotypic	response	as	well	as	integration	and	stability.	Polymeric	
bone	tissue	engineering	scaffolds	typically	suffer	from	insufficient	mechanical	strength	while	
ceramic	 and	metal	 scaffolds	 exhibit	 much	 higher	 strength.	 To	more	 closely	mimic	 native	
bone	 which	 has	 inherent	 flexibility	 and	 strength,	 composite	 materials	 can	 address	 the	
shortcomings	 of	 pure	materials.	 This	 is	 further	 complicated	 by	 the	 variation	 observed	 in	
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bone	as	well	as	the	complex	loading	conditions.	Our	material	has	been	designed	considering	
use	 as	 a	 defect	 filler	 and	 support	 for	 additional	 therapy	 in	 the	 context	 of	 trabecular	
mandibular	bone.	The	Young’s	modulus	of	[human]	mandibular	bone	has	been	reported	by	
Misch	 et	 al.	 as	 being	 between	 3.5-125.6	 MPa.	 Given	 a	 compression	 modulus	 of	
approximately	 2.4	MPa	 determined	 for	 dry	 polyHIPE	 scaffolds,	mechanical	 properties	 are	
approaching	 the	 lower	 end	 of	 native	 tissue.	 Previous	 studies	 indicated	 a	 tensile	 Young’s	
modulus	 of	 19	 MPa	 for	 this	 material37.	 Principally,	 this	 discrepancy	 arises	 from	 the	 size	
difference	between	compression	and	tensile	samples	and	the	lower	strain	that	was	applied	
in	 compression	 compared	 to	 tension.	 At	 present,	 hydroxyapatite	 is	 incorporated	 by	
polymerising	 the	network	around	particles	and	 the	 level	of	 interaction	 is	 limited.	This	has	
implications	 for	 the	degree	of	 strengthening	which	can	be	attained	and	there	 is	 scope	 for	
improving	the	transference	of	load	between	the	polymer	and	the	ceramic	phase.		
No	significant	adverse	effects	were	observed	during	culture	of	MG63	cells	on	any	of	the	
polyHIPE	 scaffolds	 compared	 to	 Alvetex®	 cultures.	 Cell	 penetration	 into	 the	 scaffolds	
remained	high	across	all	samples	with	colonisation	sustained	throughout	the	scaffold	over	
the	culture	period.	Preliminary	results	indicate	that	the	incorporation	of	hydroxyapatite	and	
strontium-modified	 hydroxyapatite	 into	 the	 scaffold	 both	 enhances	 mineralisation	 and	
promotes	an	earlier	onset	of	mineralisation.	Furthermore,	the	incorporation	of	Sr	appears	to	
enhance	 mineralization	 across	 all	 timepoints.	 As	 limited	 mineralisation	 has	 occurred	 in	
samples	 without	 added	 ceramic,	 the	 observed	 changes	 are	 likely	 to	 occur	 through	
redistribution	of	hydroxyapatite,	indicating	its	bioavailability.	
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The	 presence	 of	 strontium	 appears	 to	 enhance	 osteoblastic	 cell	 proliferation.	
Strontium-modified	 hydroxyapatite	 was	 shown	 to	 result	 in	 a	 more	 rapid	 formation	 of	 a	
surface	 apatite	 layer	 in	 simulated	 body	 fluid	 experiments	 than	 hydroxyapatite,	 indicating	
enhanced	 bioactivity57.	 Replacement	 of	 some	 of	 the	 Ca	 by	 Sr	 influences	 hydroxyapatite	
dissolution	behaviour.	The	same	study	also	showed	enhanced	osteoprecursor	cell	adhesion	
on	 SrHA	 surfaces	 compared	 to	HA,	 promoted	 an	 osteoblastic	 phenotype	 and	 significantly	
increased	cell	proliferation.	
ALP	 expression	 is	 highest	 on	 scaffolds	 without	 added	 hydroxyapatites,	 and	 in	 most	
cases	 diminishes	 as	 time	 progresses.	 It	 is	 known	 that	 ALP	 is	 down-regulated	 once	
mineralization	 is	 established59.	 Polak	 et	 al.	 observed	 a	 large	 reduction	 in	 levels	 of	 ALP	
activity	between	days	2	and	12	of	osteoblast	culture	on	bioactive	glass60.	At	the	same	time,	
calcified	bone	nodule	 formation	was	observed	on	bioglass	 surfaces	 as	 early	 as	 day	 6.	 Rat	
osteoblasts61	 cultured	 in	 the	 presence	 of	 calcium	 phosphate	 bioceramics,	 including	 HA,	
displayed	a	rapid	drop	in	ALP	expression	levels	after	day	3.	Addition	of	soluble	calcium	to	3D	
cultures	of	MG63	cells	has	similarly	been	shown	to	enhance	mineralization	and,	to	a	lesser	
extent,	down-regulate	ALP	expression62.	We	hypothesise	therefore	that	the	presence	of	HA	
or	 SrHA	 encourages	 early	 mineralization	 of	 scaffolds,	 which	 in	 turn	 results	 in	 a	 down-
regulation	of	ALP,	 in	 comparison	 to	 scaffolds	without	added	bioceramic.	This	explains	 the	
observed	 formation	 of	 calcium-	 and	 phosphate-rich	 nodules	 as	 well	 as	 the	 significantly	
lower	levels	of	ALP	expression	at	day	7	in	the	presence	of	HA	and	SrHA,	compared	to	control	
scaffolds.	
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While	 the	 current	 approach	 taken	 is	 unable	 to	 quantify	 the	 contributions	 to	 the	
microenvironment	 which	 trigger	 mineralisation	 events	 in	 these	 scaffolds,	 strontium-
substitution	into	hydroxyapatite	appears	to	result	in	more	reliable	and	earlier	formation	of	
bone	nodules.	Hydroxyapatite	by	itself	can	produce	larger	regions	of	mineralisation	even	if	
the	occurrence	 is	 rarer.	 Further	 investigation	 into	 the	osteogenic	gene	expression	profiles	
may	 better	 elucidate	 and	quantify	 the	 difference	 between	hydroxyapatite	 and	 strontium-
substituted	hydroxyapatite	 in	 these	 scaffolds.	Primary	evaluation	of	 the	 scaffold	materials	
has	 been	 accomplished	 using	 thin	 scaffold	 sections	 of	 approximately	 200µm	 thick	 which	
limits	 the	 maximum	 diffusion	 distance	 to	 cells.	 For	 translation	 to	 an	 in	 vivo	 context,	
sufficient	vascularisation	will	be	required	to	support	growth	into	the	scaffold	as	well	as	host	
integration.	 As	 such,	 controllable	 enlargement	 of	 internal	 voids	 coupled	 with	 strength	
compensation	remains	the	crux	for	future	scaffold	development.	
	
Conclusions	
It	 has	 been	 demonstrated	 that	 thiol-acrylate	 polyHIPEs	 can	 be	 fabricated	 as	
nanocomposites	containing	ceramic	nanoparticle	inclusions.	The	content	of	the	formulation	
can	have	significant	effects	on	the	morphology	of	the	scaffold	formed	with	a	relatively	high	
particle	loading	negatively	affecting	the	stability	of	the	emulsion.	MG63	cells	cultured	on	the	
bioceramic	 composite	 scaffolds	 showed	 improved	 mineralisation	 compared	 with	 those	
cultured	on	polymer-only	scaffolds	which	highlights	the	bioavailability	of	hydroxyapatite	to	
the	 culture.	 Furthermore,	 cell	 proliferation	 was	 enhanced	 on	 composite	 scaffolds,	 in	
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particular	 those	 containing	 Sr.	 High	 cell	 densities	 maintained	 over	 the	 extended	 culture	
period	are	evidence	that	the	scaffolds	are	biocompatible.	Further	work	to	tailor	the	scaffold	
to	 better	 support	 osteogenesis	 as	 well	 as	 in	 vivo	 evaluation	 will	 be	 needed	 to	 progress	
towards	in	situ	bone	tissue	engineering	for	defect	repair.	
	
Acknowledgements	
The	 authors	 acknowledge	 the	 use	 of	 facilities	within	 the	Monash	 Centre	 for	 Electron	
Microscopy	 and	 the	 Clive	 and	 Vera	 Ramaciotti	 Centre	 for	 Structural	 Cryo-Electron	
Microscopy	as	well	as	the	scientific	and	technical	assistance	of	Monash	Histology	Platform,	
Department	 of	 Anatomy	 and	 Developmental	 Biology,	Monash	University.	 In	 addition,	 the	
authors	acknowledge	contributions	from	Aaron	Seeber,	Winston	Liew,	Thomas	Gengenbach,	
Yesim	Gozukara	from	the	Commonwealth	Scientific	and	Industrial	Research	Organisation	for	
their	technical	assistance.	
	
References	
1.	 A.	R.	Amini,	C.	T.	Laurencin	and	S.	P.	Nukavarapu,	Crit.	Rev.	Biomed.	Eng.,	2012,	40,	
363-408.	
2.	 H.-S.	 Roh,	 S.-C.	 Jung,	M.-S.	 Kook	 and	B.-H.	 Kim,	Appl.	 Surf.	 Sci.,	 2016,	388,	 Part	A,	
321-330.	
3.	 S.	Taherkhani	and	F.	Moztarzadeh,	J.	Appl.	Polym.	Sci.,	2016,	133.	
4.	 E.	Tayton,	M.	Purcell,	A.	Aarvold,	J.	O.	Smith,	S.	Kalra,	A.	Briscoe,	K.	Shakesheff,	S.	M.	
41	
	
	
Howdle,	D.	G.	Dunlop	and	R.	O.	Oreffo,	Acta	Biomater.,	2012,	8,	1918-1927.	
5.	 Y.	 Zhang,	 J.	 R.	 Venugopal,	 A.	 El-Turki,	 S.	 Ramakrishna,	 B.	 Su	 and	 C.	 T.	 Lim,	
Biomaterials,	2008,	29,	4314-4322.	
6.	 N.	R.	Cameron,	Polymer,	2005,	46,	1439-1449.	
7.	 N.	 R.	 Cameron,	 P.	 Krajnc	 and	 M.	 S.	 Silverstein,	 in	 Porous	 Polymers,	 eds.	 M.	 S.	
Silverstein,	N.	R.	Cameron	and	M.	A.	Hillmyer,	Wiley	&	Sons,	Hoboken,	N.J.,	2011,	pp.	
119-172.	
8.	 R.	J.	Carnachan,	M.	Bokhari,	S.	A.	Przyborski	and	N.	R.	Cameron,	Soft	Matter,	2006,	2,	
608-616.	
9.	 S.	D.	Kimmins	and	N.	R.	Cameron,	Adv.	Funct.	Mater.,	2011,	21,	211-225.	
10.	 I.	Pulko	and	P.	Krajnc,	Macromol.	Rapid	Commun.,	2012,	33,	1731-1746.	
11.	 M.	S.	Silverstein,	Prog.	Polym.	Sci.,	2014,	39,	199-234.	
12.	 M.	S.	Silverstein,	Polymer,	2014,	55,	304-320.	
13.	 D.	Barby	and	Z.	Haq,	EP	Pat.,	60138,	1982.	
14.	 J.	M.	Williams,	Langmuir,	1988,	4,	44-49.	
15.	 H.	F.	Zhang	and	A.	I.	Cooper,	Soft	Matter,	2005,	1,	107-113.	
16.	 E.	Ruckenstein,	Adv.	Polym.	Sci.,	1997,	127,	1-58.	
17.	 K.	Haibach,	A.	Menner,	R.	Powell	and	A.	Bismarck,	Polymer,	2006,	47,	4513-4519.	
18.	 K.	 J.	 Lissant	 (ed.),	 Emulsions	 and	 Emulsion	 Technology	 Part	 1,	Marcel	 Dekker	 Inc.,	
New	York,	1974.	
19.	 G.	Akay,	Z.	Bhumgara	and	R.	J.	Wakeman,	Chem.	Eng.	Res.	Des.,	1995,	73,	782-797.	
42	
	
	
20.	 P.	Krajnc,	N.	Leber,	 J.	F.	Brown	and	N.	R.	Cameron,	React.	Funct.	Polym.,	2006,	66,	
81-91.	
21.	 G.	H.	Ruan,	Z.	W.	Wu,	Y.	P.	Huang,	M.	P.	Wei,	R.	H.	Su	and	F.	Y.	Du,	Biochem.	Biophys.	
Res.	Commun.,	2016,	473,	54-60.	
22.	 R.	H.	Su,	G.	H.	Ruan,	H.	G.	Nie,	T.	Xie,	Y.	J.	Zheng,	F.	Y.	Du	and	J.	P.	Li,	J.	Chromatogr.	
A,	2015,	1405,	23-31.	
23.	 P.	W.	Small	and	D.	C.	Sherrington,	J.	Chem.	Soc.,	Chem.	Commun.,	1989,	1589-1591.	
24.	 H.	Deleuze,	B.	Maillard	and	O.	Mondain-Monval,	Bioorg.	Med.	Chem.	Lett.,	2002,	12,	
1877-1880.	
25.	 S.	Hus,	M.	Kolar	and	P.	Krajnc,	J.	Chromatogr.	A,	2016,	1437,	168-175.	
26.	 S.	Kovacic,	M.	Mazaj,	M.	Jeselnik,	D.	Pahovnik,	E.	Zagar,	C.	Slugovc	and	N.	Z.	Logar,	
Macromol.	Rapid	Commun.,	2015,	36,	1605-1611.	
27.	 G.	Akay,	M.	Birch	and	M.	Bokhari,	Biomaterials,	2004,	25,	3991-4000.	
28.	 M.	W.	Hayman,	K.	H.	Smith,	N.	R.	Cameron	and	S.	A.	Przyborski,	Biochem.	Biophys.	
Res.	Commun.,	2004,	314,	483-488.	
29.	 M.	A.	Bokhari,	G.	Akay,	S.	Zhang	and	M.	A.	Birch,	Biomaterials,	2005,	26,	5198-5208.	
30.	 M.	W.	Hayman,	K.	H.	Smith,	N.	R.	Cameron	and	S.	A.	Przyborski,	J.	Biochem.	Biophys.	
Methods,	2005,	62,	231-240.	
31.	 M.	Bokhari,	R.	 J.	Carnachan,	N.	R.	Cameron	and	S.	A.	Przyborski,	Biochem.	Biophys.	
Res.	Commun.,	2007,	354,	1095-1100.	
32.	 M.	Bokhari,	R.	J.	Carnachan,	N.	R.	Cameron	and	S.	A.	Przyborski,	J.	Anat.,	2007,	211,	
43	
	
	
567-576.	
33.	 M.	 Bokhari,	 R.	 J.	 Carnachan,	 S.	 A.	 Przyborski	 and	N.	 R.	 Cameron,	 J.	Mater.	 Chem.,	
2007,	17,	4088-4094.	
34.	 E.	 M.	 Christenson,	 W.	 Soofi,	 J.	 L.	 Holm,	 N.	 R.	 Cameron	 and	 A.	 G.	 Mikos,	
Biomacromolecules,	2007,	8,	3806-3814.	
35.	 E.	Knight,	B.	Murray,	R.	Carnachan	and	S.	Przyborski,	in	3D	Cell	Culture:	Methods	and	
Protocols,	2011,	vol.	695,	pp.	323-340.	
36.	 R.	 S.	Moglia,	 J.	 L.	 Holm,	 N.	 A.	 Sears,	 C.	 J.	Wilson,	 D.	M.	 Harrison	 and	 E.	 Cosgriff-
Hernandez,	Biomacromolecules,	2011,	12,	3621-3628.	
37.	 S.	Caldwell,	D.	W.	Johnson,	M.	P.	Didsbury,	B.	A.	Murray,	J.	J.	Wu,	S.	A.	Przyborski	and	
N.	R.	Cameron,	Soft	Matter,	2012,	8,	10344-10351.	
38.	 A.	 S.	 Hayward,	 A.	 M.	 Eissa,	 D.	 J.	 Maltman,	 N.	 Sano,	 S.	 A.	 Przyborski	 and	 N.	 R.	
Cameron,	Biomacromolecules,	2013,	14,	4271-4277.	
39.	 A.	 S.	 Hayward,	 N.	 Sano,	 S.	 A.	 Przyborski	 and	 N.	 R.	 Cameron,	 Macromol.	 Rapid	
Commun.,	2013,	34,	1844-1849.	
40.	 S.	Zhou,	A.	Bismarck	and	J.	H.	G.	Steinke,	J.	Mater.	Chem.	B,	2013,	1,	4736-4745.	
41.	 R.	Owen,	C.	Sherborne,	G.	C.	Reilly	and	F.	Claeyssens,	Data	Brief,	2015,	5,	616-620.	
42.	 M.	Susec,	R.	Liska,	G.	Russmuller,	J.	Kotek	and	P.	Krajnc,	Macromol.	Biosci.,	2015,	15,	
253-261.	
43.	 J.	Naranda,	M.	Susec,	U.	Maver,	L.	Gradisnik,	M.	Gorenjak,	A.	Vukasovic,	A.	 Ivkovic,	
M.	S.	Rupnik,	M.	Vogrin	and	P.	Krajnc,	Sci.	Rep.,	2016,	6.	
44	
	
	
44.	 R.	Owen,	 C.	 Sherborne,	 T.	 Paterson,	N.	H.	Green,	G.	 C.	 Reilly	 and	 F.	 Claeyssens,	 J.	
Mech.	Behav.	Biomed.	Mater.,	2016,	54,	159-172.	
45.	 J.	L.	Robinson,	M.	A.	P.	McEnery,	H.	Pearce,	M.	E.	Whitely,	D.	J.	Munoz-Pinto,	M.	S.	
Hahn,	H.	Li,	N.	A.	Sears	and	E.	Cosgriff-Hernandez,	Tiss.	Eng.	Pt.	A,	2016,	22,	403-414.	
46.	 A.	Barbetta,	M.	Massimi,	L.	C.	Devirgiliis	and	M.	Dentini,	Biomacromolecules,	2006,	7,	
3059-3068.	
47.	 A.	Barbetta,	M.	Massimi,	B.	Di	Rosario,	S.	Nardecchia,	M.	De	Colli,	L.	C.	Devirgiliis	and	
M.	Dentini,	Biomacromolecules,	2008,	9,	2844-2856.	
48.	 M.	De	Colli,	M.	Massimi,	A.	Barbetta,	B.	L.	Di	Rosario,	S.	Nardecchia,	L.	C.	Devirgiliis	
and	M.	Dentini,	Biomed.	Mater.,	2012,	7,	055005.	
49.	 J.	 L.	 Robinson,	 R.	 S.	 Moglia,	 M.	 C.	 Stuebben,	 M.	 A.	 P.	 McEnery	 and	 E.	 Cosgriff-
Hernandez,	Tiss.	Eng.	Pt.	A,	2014,	20,	1103-1112.	
50.	 E.	 Lovelady,	 S.	D.	Kimmins,	 J.	Wu	and	N.	R.	Cameron,	Polym.	Chem.,	 2011,	2,	 559-
562.	
51.	 D.	W.	 Johnson,	 C.	 R.	 Langford,	M.	 P.	 Didsbury,	 B.	 Lipp,	 S.	 A.	 Przyborski	 and	 N.	 R.	
Cameron,	Polym.	Chem.,	2015,	6,	7256-7263.	
52.	 C.	R.	Langford,	D.	W.	Johnson	and	N.	R.	Cameron,	Macromol.	Rapid	Commun.,	2015,	
36,	834-839.	
53.	 B.	Fernández-Montes	Moraleda,	S.	Román	and	L.	M.	Rodríguez-Lorenzo,	 J.	Biomed.	
Mater.	Res.	Pt.	A,	2016.	
54.	 L.	 M.	 Rodriguez-Lorenzo,	 in	 Apatite:	 Synthesis,	 Structural	 Characterization	 and	
45	
	
	
Biomedical	Applications,	eds.	M.	 Iafisco	and	J.	M.	Delgado	Lopez,	NOVA	Publishers,	
Hauppage,	NY,	2014.	
55.	 A.	Barbetta	and	N.	R.	Cameron,	Macromolecules,	2004,	37,	3202-3213.	
56.	 A.	Barbetta	and	N.	R.	Cameron,	Macromolecules,	2004,	37,	3188-3201.	
57.	 W.	C.	Xue,	J.	L.	Moore,	H.	L.	Hosick,	S.	Bose,	A.	Bandyopadhyay,	W.	W.	Lu,	K.	M.	C.	
Cheung	and	K.	D.	K.	Luk,	J.	Biomed.	Mater.	Res.	Pt.	A,	2006,	79A,	804-814.	
58.	 J.	E.	Aubin,	in	Principles	of	Bone	Biology	(Third	Edition),	eds.	J.	P.	Bilezikian,	L.	G.	Raisz	
and	T.	J.	Martin,	Academic	Press,	Cambridge,	MA,	2008,	vol.	1.	
59.	 T.	A.	Owen,	M.	Aronow,	V.	Shalhoub,	L.	M.	Barone,	L.	Wilming,	M.	S.	Tassinari,	M.	B.	
Kennedy,	S.	Pockwinse,	J.	B.	Lian	and	G.	S.	Stein,	J.	Cell.	Physiol.,	1990,	143,	420-430.	
60.	 I.	D.	Xynos,	M.	V.	J.	Hukkanen,	J.	J.	Batten,	L.	D.	Buttery,	L.	L.	Hench	and	J.	M.	Polak,	
Calcified	Tissue	Int.,	2000,	67,	321-329.	
61.	 J.	S.	Sun,	Y.	H.	Tsuang,	C.	J.	Liao,	H.	C.	Liu,	Y.	S.	Hang	and	F.	H.	Lin,	J.	Biomed.	Mater.	
Res.,	1997,	37,	324-334.	
62.	 Y.	Takagishi,	T.	Kawakami,	Y.	Hara,	M.	Shinkai,	T.	Takezawa	and	T.	Nagamune,	Tiss.	
Eng.,	2006,	12,	927-937.	
	
